Trend toward earlier treatment of uveal melanoma observed

CHICAGO — “Despite identification of risk factors, many ophthalmologists still observe borderline lesions, waiting for growth before initiating treatment of uveal melanomas,” Jerry A. Shields, MD, said in his delivery of the Charles L. Schepens, MD, Lecture here.That trend, however, is not reflected in how cancers in other specialties are managed.

Full Story →